Skip to main content
PMC home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1984 Jun;25(6):760–763. doi: 10.1128/aac.25.6.760

Distribution of ceftazidime in ascitic fluid.

G Benoni, E Arosio, M G Raimondi, E Apolloni, E Passarella, A Lechi, G P Velo
PMCID: PMC185636  PMID: 6378086

Abstract

The pharmacokinetics of ceftazidime were investigated in eight normal subjects and eight patients with ascites after intravenous administration of 1 g of the drug. Samples of blood and ascitic fluid were collected for 6 h after dosage, and urine samples were collected for 24 h. Pharmacokinetic data were calculated by using a one-compartment model. The apparent volume of distribution and half-life of elimination (t1/2 beta) in patients with ascites were approximately three times those in normal subjects. In contrast, renal clearance was greater in the normal subjects. With respect to ascites, the mean area under the concentration-time curve was 95.3 +/- 38.3 micrograms X h/ml. The mean ratio of the area under the concentration-time curve for ascitic fluid to that for plasma was 69.9% (+/- 38.2). These data show that ceftazidime rapidly diffuses into the peritoneal space, in which concentrations greater than 10 micrograms/ml were present for at least 6 h.

Full text

PDF
760

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Chalas J., Labayle D., Macarrio J., Barraud D., Lindenbaum A., Buffet C., Chaput J. C. Métabolisme et cinétique de l'élimination de l'ampicilline dans la cirrhose. Conséquences thérapeutiques. Sem Hop. 1980 Mar 8;56(9-10):464–469. [PubMed] [Google Scholar]
  2. Eickenberg H. U. Interstitial concentration of antibiotics and their significance for an adequate dosage. Infection. 1980;Suppl 1:39–44. doi: 10.1007/BF01644934. [DOI] [PubMed] [Google Scholar]
  3. Garcia M. J., Dominguez-Gil A., Perez F. D., Rodriguez F. P., Moronta F. D. Disposition of cefoxitin in patients with ascites. Eur J Clin Pharmacol. 1981;20(5):371–374. doi: 10.1007/BF00615407. [DOI] [PubMed] [Google Scholar]
  4. Gillett A. P., Wise Penetration of four cephalosporins into tissue fluid in man. Lancet. 1978 May 6;1(8071):962–964. doi: 10.1016/s0140-6736(78)90250-7. [DOI] [PubMed] [Google Scholar]
  5. Krothapalli R., Duffy W. B., Lacke C., Payne W., Patel H., Perez V., Senekjian H. O. Pseudomonas peritonitis and continuous ambulatory peritoneal dialysis. Arch Intern Med. 1982 Oct;142(10):1862–1863. [PubMed] [Google Scholar]
  6. Laber G., Schütze E., Leskova R., Kolb R., Georgopoulos A. A diffusion chamber technique for measuring concentrations of antibiotics in interstitial fluid. Infection. 1980;8(2):58–62. doi: 10.1007/BF01639147. [DOI] [PubMed] [Google Scholar]
  7. Lechi A., Arosio E., Xerri L., Mengoli C., Montesi G., Ghidini O. The kinetics of cefuroxime in ascitic and pleural fluid. Int J Clin Pharmacol Ther Toxicol. 1982 Oct;20(10):493–496. [PubMed] [Google Scholar]
  8. Leeder J. S., Spino M., Tesoro A. M., MacLeod S. M. High-pressure liquid chromatographic analysis of ceftazidime in serum and urine. Antimicrob Agents Chemother. 1983 Nov;24(5):720–724. doi: 10.1128/aac.24.5.720. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Lewis G. P., Jusko W. J. Pharmacokinetics of ampicillin in cirrhosis. Clin Pharmacol Ther. 1975 Oct;18(4):475–484. doi: 10.1002/cpt1975184475. [DOI] [PubMed] [Google Scholar]
  10. Magera B. E., Arroyo J. C., Rosansky S. J., Postic B. Vancomycin pharmacokinetics in patients with peritonitis on peritoneal dialysis. Antimicrob Agents Chemother. 1983 May;23(5):710–714. doi: 10.1128/aac.23.5.710. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Moreau L., Durand H., Biclet P. Cefotaxime concentrations in ascites. J Antimicrob Chemother. 1980 Sep;6 (Suppl A):121–122. doi: 10.1093/jac/6.suppl_a.121. [DOI] [PubMed] [Google Scholar]
  12. O'Callaghan C. H., Acred P., Harper P. B., Ryan D. M., Kirby S. M., Harding S. M. GR 20263, a new broad-spectrum cephalosporin with anti-pseudomonal activity. Antimicrob Agents Chemother. 1980 May;17(5):876–883. doi: 10.1128/aac.17.5.876. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Parrott P. L., Terry P. M., Whitworth E. N., Frawley L. W., Coble R. S., Wachsmuth I. K., McGowan J. E., Jr Pseudomonas aeruginosa peritonitis associated with contaminated poloxamer-iodine solution. Lancet. 1982 Sep 25;2(8300):683–685. doi: 10.1016/s0140-6736(82)90712-7. [DOI] [PubMed] [Google Scholar]
  14. Peterson L. R., Gerding D. N. Influence of protein binding of antibiotics on serum pharmacokinetics and extravascular penetration: clinically useful concepts. Rev Infect Dis. 1980 May-Jun;2(3):340–348. doi: 10.1093/clinids/2.3.340. [DOI] [PubMed] [Google Scholar]
  15. Simon C., Malerczyk V., Müller U., Müller G. Zur Pharmakokinetik von Propicillin bei geriatrischen Patienten im Verglich zu jüngeren Erwachsenen. Dtsch Med Wochenschr. 1972 Dec 29;97(52):1999–2003. doi: 10.1055/s-0028-1107695. [DOI] [PubMed] [Google Scholar]
  16. Swabb E. A., Leitz M. A., Pilkiewicz F. G., Sugerman A. A. Pharmacokinetics of the monobactam SQ 26,776 after single intravenous doses in healthy subjects. J Antimicrob Chemother. 1981 Dec;8 (Suppl E):131–140. doi: 10.1093/jac/8.suppl_e.131. [DOI] [PubMed] [Google Scholar]
  17. Trager G. M., White G. W., Zimelis V. M., Panwalker A. P. LY-127935: a novel beta-lactam antibiotic with unusual antibacterial activity. Antimicrob Agents Chemother. 1979 Sep;16(3):297–300. doi: 10.1128/aac.16.3.297. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Verbist L., Verhaegen J. GR-20263: a new aminothiazolyl cephalosporin with high activity against Pseudomonas and Enterobacteriaceae. Antimicrob Agents Chemother. 1980 May;17(5):807–812. doi: 10.1128/aac.17.5.807. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Wilson D. E., Chalmers T. C., Madoff M. A. The passage of cephalothin into and out of ascitic fluid. Am J Med Sci. 1967 Apr;253(4):449–452. doi: 10.1097/00000441-196704000-00007. [DOI] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES